2018
DOI: 10.1038/s41586-018-0392-8
|View full text |Cite
|
Sign up to set email alerts
|

Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response

Abstract: Tumour cells evade immune surveillance by upregulating the surface expression of programmed death-ligand 1 (PD-L1), which interacts with programmed death-1 (PD-1) receptor on T cells to elicit the immune checkpoint response. Anti-PD-1 antibodies have shown remarkable promise in treating tumours, including metastatic melanoma. However, the patient response rate is low. A better understanding of PD-L1-mediated immune evasion is needed to predict patient response and improve treatment efficacy. Here we report tha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

61
1,756
5
5

Year Published

2019
2019
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 1,868 publications
(1,827 citation statements)
references
References 33 publications
61
1,756
5
5
Order By: Relevance
“…Exosomes are a well‐known driver of cancer progression, and can influence cancer and non‐cancer cell types. Notably, exosomes have recently been implicated in immunosuppression via the presence of PD‐L1 on the surface of melanoma exosomes …”
Section: Introductionmentioning
confidence: 99%
“…Exosomes are a well‐known driver of cancer progression, and can influence cancer and non‐cancer cell types. Notably, exosomes have recently been implicated in immunosuppression via the presence of PD‐L1 on the surface of melanoma exosomes …”
Section: Introductionmentioning
confidence: 99%
“…However, not all patients have derived clinical benefits from PD-1/PD-L1 therapy, and the molecular mechanisms underlying the regulation of T cells in GIST are not elucidated. This observation is explained by the latest study, which reports that cancer cells can send out "drones," extracellular vesicles mostly in the form of exosomes that carry PD-L1 on their surface, to battle the immune system from afar 48. Thus, it is critical to determine the mechanism by which PD-1/PD-L1 regulates CD8+ T cells to improve the design of novel CD8+ T-cell-based immunotherapies.In this study, we found that the PD-1/PD-L1 axis contributed to immune evasion and predicted prognosis in GIST.…”
mentioning
confidence: 99%
“…Exosomes from premetastatic melanoma cells were suggested to inhibit metastasis, by instigating immune‐surveillance programs at the metastatic site . Conversely, melanoma‐secreted exosomes were recently shown to contain PD‐L1, that contributed to systemic immunosuppression in patients and with response to immunotherapy . Thus, signaling by tumor‐derived exosomes may be context dependent, and caution should be taken when designing exosome‐targeted therapeutic strategies.…”
Section: Discussionmentioning
confidence: 99%